Resources

Explore our latest research articles and industry analyses to stay ahead in the rapidly evolving biopharmaceutical landscape. From breakthrough therapies to regulatory developments, we deliver authoritative content to support your professional growth in this dynamic field.

Congratulations to the June Lab on their groundbreaking research in T-Cell Engineering!

The Carl June Lab has once again advanced the frontiers of immunotherapy research with their recently published study, “Stem Loop Mediated Transgene Modulation in Human T Cells” featured in ACS Synthetic Biology.
2025/02/04

Exciting News for CARVYKTI®!

Johnson & Johnson has just released their 2024 Annual Report, showcasing remarkable progress for Carvykti (cilta-cel), the revolutionary CAR T-cell therapy for relapsed or refractory multiple myeloma.
2025/02/04

Industry Insight: Rapid Success of EsoBiotec’s FIH IIT Program & $1B Acquisition by AstraZeneca

A landmark cell therapy industry milestone took place in early 2025: EsoBiotec kicked off its ESO-T01 First-in-Human investigator-initiated trial (FIH IIT) in Wuhan on January 8, 2025.
2025/01/30